Bond Laboratories announces revenue of $2.2 million for third-quarter

NewsGuard 100/100 Score

Bond Laboratories, Inc. (OTCBB:BNLB), a leading manufacturer and marketer of proprietary beverage products and health supplements, today announced revenue of over $2.2 million for the third quarter ended September 30, 2009, a 340% increase over revenue of approximately $500,000 for the comparable quarter in 2008. Total revenue for the nine months ended September 30, 2009 was just under $7 million as compared to approximately $1.1 million for the same period last year, an increase of over 500%.

“Bond has assembled a dedicated and highly talented team, which continually surpasses our internal financial goals. Both NDS Nutrition and Fusion Premium Beverages are dramatically expanding their distribution and revenues, as well as introducing innovative new products,” stated John Wilson, Chief Executive Officer of Bond Laboratories.

Losses from operations for the three months and nine months ended September 30, 2009 were approximately $677,000 and $1.6 million, respectively, compared to losses from operations of approximately $987,000 and $3.8 million for the same periods last year.

“Excluding non-cash expenses, net loss for the third quarter in 2009 was less than $350,000 as compared to a net loss of approximately $950,000 for the comparable quarter last year, an improvement of more than 63%. Bond continues to experience dramatic progress across all areas of its business and remains committed to driving rapid revenue growth and realizing additional cost savings as a means to achieve positive operating income in 2010,” concluded Wilson.

Additional information, including consolidated financial information, will be available in Bond Laboratories’ Form 10-Q expected to be filed with the Securities and Exchange Commission in early November.

Source: Bond Laboratories, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
The whey to go: Researchers unlock the potential of whey-derived proteins for cancer prevention